Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19Pierre‐François Dequin, Nicholas Heming, Ferhat Meziani et al.|JAMA|2020Cited by 518
Hydrocortisone in Severe Community-Acquired PneumoniaPierre‐François Dequin, Amélie Le Gouge, Ferhat Meziani et al.|New England Journal of Medicine|2023Cited by 438
Prevention of Early Ventilator-Associated Pneumonia after Cardiac ArrestBruno François, Amélie Le Gouge, Alain Cariou et al.|New England Journal of Medicine|2019Cited by 185
Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trialBruno François, Emmanuelle Mercier, Céline Gonzalez et al.|Intensive Care Medicine|2018Cited by 110
Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical TrialAnahita Rouzé, Saad Nseir, Pierre Asfar et al.|American Journal of Respiratory and Critical Care Medicine|2021Cited by 103